Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O H Arnold

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Arzneimittel-Forschung|January 1, 1976
[Adenylat-kinase-Systeme, ein Beitrag zum manisch-depressiven Kranksein (MDK)]O H Arnold
Psychopathology|January 1, 1985
Schizophrenic thought disorders: comparison between units of symptoms and axial syndromeO H Arnold
Neuropsychobiology|July 27, 1999
Schizophrenia - A disturbance of signal interaction between the entorhinal cortex and the dentate gyrus? The contribution of experimental dibenamine psychosis to the pathogenesis of schizophrenia: A hypothesisO H Arnold
Psychiatria Clinica|January 1, 1983
Levels of interaction between schizophrenia and manic-depressive diseaseO H Arnold
Lebensversicherungs Medizin|November 1, 1972
[Increase of life expectancy through hypertension treatment]O H Arnold
Arzneimittel-Forschung|August 1, 1974
[Further observations on "automation-like" existence under long-term lithium therapy]O H Arnold
Arzneimittel-Forschung|June 1, 1975
[N,N-dimethyltryptamine: first comparative results. Preliminary communication]O H Arnold
Zeitschrift Fur Allgemeinmedizin|August 20, 1971
[The primary arterial hypertension]O H Arnold
Experimentelle Medizin, Pathologie Und Klinik|January 1, 1970
[Therapy of arterial hypertension. Results, possibilities, methods]O H Arnold
Behavioral Neuropsychiatry|February 1, 1972
Correlations between clinical and biochemical data in schizophreniaO H Arnold, G Hofmann
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Arzneimittel-Forschung|January 1, 1976
[Adenylat-kinase-Systeme, ein Beitrag zum manisch-depressiven Kranksein (MDK)]O H Arnold
Psychopathology|January 1, 1985
Schizophrenic thought disorders: comparison between units of symptoms and axial syndromeO H Arnold
Neuropsychobiology|July 27, 1999
Schizophrenia - A disturbance of signal interaction between the entorhinal cortex and the dentate gyrus? The contribution of experimental dibenamine psychosis to the pathogenesis of schizophrenia: A hypothesisO H Arnold
Psychiatria Clinica|January 1, 1983
Levels of interaction between schizophrenia and manic-depressive diseaseO H Arnold
Lebensversicherungs Medizin|November 1, 1972
[Increase of life expectancy through hypertension treatment]O H Arnold
Arzneimittel-Forschung|August 1, 1974
[Further observations on "automation-like" existence under long-term lithium therapy]O H Arnold
Arzneimittel-Forschung|June 1, 1975
[N,N-dimethyltryptamine: first comparative results. Preliminary communication]O H Arnold
Zeitschrift Fur Allgemeinmedizin|August 20, 1971
[The primary arterial hypertension]O H Arnold
Experimentelle Medizin, Pathologie Und Klinik|January 1, 1970
[Therapy of arterial hypertension. Results, possibilities, methods]O H Arnold
Behavioral Neuropsychiatry|February 1, 1972
Correlations between clinical and biochemical data in schizophreniaO H Arnold, G Hofmann
Pageof 2